newsfilter
← Latest News
GlobeNewswire·

Acasti Announces Poster Detailing its GTX-104 STRIVE-ON Trial

PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ:ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel formulation of nimodipine that addresses the